vimarsana.com

Page 19 - பிரிட்டன் கூட்டு குழு ஆன் தடுப்பூசி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

UK vaccine committee advises against use of AstraZeneca jab in under-30s

UK vaccine committee advises against use of AstraZeneca jab in under-30s Alternative vaccines against Covid-19 should be used for under-30s due to blood-clot risk about 4 hours ago The UK committee on vaccination advised use of alternative vaccines to AstraZeneca’s against Covid-19. Photograph: Thomas Kienzle/AFP via Getty Images   Britain should not give Oxford/AstraZeneca’s Covid-19 vaccine to under 30s where possible, Britain’s Joint Committee on Vaccination and Immunisation (JCVI) said on Wednesday, due to a very rare side effect of blood clots in the brain. Wei Shen Lim, Covid-19 Chair for JCVI, said that based on the available data and evidence, the committee has advised that it is preferable for adults aged under 30 with no underlying conditions to be offered an alternative to the AstraZeneca vaccine where available.

Overnight Health Care: UK coronavirus variant now most common strain in US | Over 500K sign up for ObamaCare in special period | EU finds possible link between AstraZeneca vaccine, blood clots

Overnight Health Care: UK coronavirus variant now most common strain in US | Over 500K sign up for ObamaCare in special period | EU finds possible link between AstraZeneca vaccine, blood clots
thehill.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehill.com Daily Mail and Mail on Sunday newspapers.

UK vaccine panel says under-30s should not receive Oxford/AstraZeneca vaccine

Hibbing, MN, USA / 93.9 WTBX Apr 7, 2021 9:44 AM LONDON (Reuters) - Britain should not give Oxford University/AstraZeneca s vaccine to under 30s where possible, Britain s Joint Committee on Vaccination and Immunisation (JCVI) said on Wednesday, due to a very rare side effect of blood clots in the brain. Based on the available data and evidence, JCVI has advised that it is preferable for adults aged under 30 with no underlying conditions to be offered an alternative to the AstraZeneca vaccine where available, said Wei Shen Lim, COVID-19 Chair for JCVI. (Reporting by Alistair Smout, Guy Faulconbridge and Kate Holton; editing by James Davey)

Britain says: do not give Oxford/AstraZeneca vaccine to under-30s

4 Min Read LONDON (Reuters) -Britain should give an alternative to Oxford/AstraZeneca’s COVID-19 vaccine to under 30s where possible due to a “vanishingly” rare side effect of blood clots in the brain, Britain’s vaccine advisory committee said on Wednesday. Officials said the benefits of the shot continued to outweigh its risks for the vast majority, after safety concerns spurred over a dozen countries in recent weeks to suspend use of the vaccine following reports linking it to a brain blood clotting disorder. Britain has kept using the shot throughout. Wei Shen Lim, chair of Britain’s Joint Committee on Vaccination and Immunisation (JCVI), said that based on the available data and evidence, it was preferable for adults aged under 30 with no underlying conditions to be offered an alternative to the AstraZeneca vaccine where available.

UK advises limiting AstraZeneca in under-30 group amid blood clot worry

UK advises limiting AstraZeneca in under-30 group amid blood clot worry
pbs.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pbs.org Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.